Disclosures for "Safety, Efficacy and Pharmacokinetics of HS-10506 in the Insomnia Patients: A Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Study"
-
The institution of Dr. Wang has received research support from National Science Fundation of China .
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose